Theralink Technologies, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Charles L Jr Rice. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Charles L Jr Rice has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:OBMP / Theralink Technologies Inc Director 3,000,000
US:ETR / Entergy Corporation 4,177
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Charles L Jr Rice. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases THER / Theralink Technologies, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in THER / Theralink Technologies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THER / Theralink Technologies, Inc. Insider Trades
Insider Sales THER / Theralink Technologies, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in THER / Theralink Technologies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THER / Theralink Technologies, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Charles L Jr Rice as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2019-04-30 2019-04-24 4 OBMP OncBioMune Pharmaceuticals, Inc
Employee Stock Option (right to buy)
A - Award 3,000,000 3,000,000
2019-04-24 2018-01-29 4/A ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -137 4,177 -3.18 78.63 -10,772 328,438
2019-04-24 2017-01-30 4/A ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -103 4,440 -2.27 70.61 -7,273 313,508
2019-04-24 2017-01-30 4/A ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -121 4,543 -2.59 70.61 -8,544 320,781
2019-03-14 2018-05-09 4/A OBMP OncBioMune Pharmaceuticals, Inc
Stock Option (right to buy)
A - Award 3,000,000 3,000,000
2019-03-14 2017-04-17 4/A OBMP OncBioMune Pharmaceuticals, Inc
Stock Option (right to buy)
A - Award 350,000 350,000
2018-08-07 2018-08-07 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -1,300 2,600 -33.33
2018-08-07 2018-08-07 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -4,466 2,234 -66.66
2018-08-07 2018-08-07 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -1,300 4,171 -23.76 82.69 -107,497 344,900
2018-08-07 2018-08-07 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 1,300 5,471 31.17 70.53 91,689 385,870
2018-08-07 2018-08-07 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -4,466 4,171 -51.71 82.70 -369,338 344,942
2018-08-07 2018-08-07 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 4,466 8,637 107.07 70.56 315,121 609,427
2018-05-11 2018-05-09 4 OBMP OncBioMune Pharmaceuticals, Inc
Option (right to buy)
A - Award 3,000,000 3,350,000 857.14
2018-01-31 2018-01-29 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -99 4,078 -2.37 78.63 -7,784 320,653
2018-01-31 2018-01-28 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -137 4,177 -3.18 78.63 -10,772 328,438
2018-01-30 2018-01-26 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -67 4,314 -1.53 78.29 -5,245 337,743
2018-01-29 2018-01-25 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 400 400
2018-01-29 2018-01-25 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 600 4,381 15.87
2018-01-19 2018-01-17 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -176 3,781 -4.45 78.51 -13,818 296,846
2018-01-19 2018-01-17 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 506 3,957 14.66
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -1,734 3,466 -33.35
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -4,600 0 -100.00
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -2,900 0 -100.00
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -1,734 3,416 -33.67 86.23 -149,523 294,562
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 1,734 5,150 50.76 63.17 109,537 325,326
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -4,600 3,416 -57.39 86.25 -396,750 294,630
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 4,600 8,016 134.66 71.30 327,980 571,541
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -2,900 3,416 -45.92 86.24 -250,096 294,596
2017-11-13 2017-11-09 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 2,900 6,316 84.89 72.79 211,091 459,742
2017-08-24 2017-08-23 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -1,000 3,368 -22.89 78.95 -78,950 265,904
2017-04-20 2017-04-17 4 OBMP OncBioMune Pharmaceuticals, Inc
Employee Stock Option (right to buy)
A - Award 350,000 350,000
2017-04-20 2015-11-18 4 OBMP OncBioMune Pharmaceuticals, Inc
Common Stock
A - Award 60,000 60,000
2017-02-01 2017-01-30 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -166 4,274 -3.74 70.61 -11,721 301,787
2017-02-01 2017-01-29 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -103 4,440 -2.27 70.61 -7,273 313,508
2017-02-01 2017-01-28 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -121 4,543 -2.59 70.61 -8,544 320,781
2017-01-30 2017-01-26 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 3,900 3,900
2017-01-30 2017-01-26 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 550 4,664 13.37
2017-01-20 2017-01-18 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -340 4,114 -7.63 71.89 -24,443 295,755
2017-01-20 2017-01-18 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 900 4,454 25.32
2016-08-26 2016-08-26 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -760 3,465 -17.99 79.36 -60,314 274,982
2016-05-13 2016-05-11 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -3,466 1,734 -66.65
2016-05-13 2016-05-11 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -3,466 4,179 -45.34 75.69 -262,342 316,309
2016-05-13 2016-05-11 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 3,466 7,645 82.94 63.17 218,947 482,935
2016-02-24 2016-02-23 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
M - Exercise -5,000 0 -100.00
2016-02-24 2016-02-23 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -5,000 4,131 -54.76 73.83 -369,150 304,992
2016-02-24 2016-02-23 4 ETR ENTERGY CORP /DE/
Common Stock
M - Exercise 5,000 9,131 121.04 64.60 323,000 589,863
2016-02-03 2016-01-31 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -174 4,131 -4.04 71.60 -12,458 295,780
2016-02-03 2016-01-30 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -147 4,305 -3.30 71.60 -10,525 308,238
2016-02-02 2016-01-29 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -99 4,452 -2.18 70.58 -6,987 314,222
2016-02-01 2016-01-28 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 6,700 6,700
2016-02-01 2016-01-28 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 1,100 4,551 31.87
2016-01-20 2016-01-18 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -206 3,451 -5.63 68.09 -14,027 234,979
2016-01-20 2016-01-18 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 544 3,657 17.48
2015-11-20 2015-11-18 4 OBMP OncBioMune Pharmaceuticals, Inc
Common Stock
A - Award 60,000 60,000
2015-05-28 2015-05-26 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -599 2,996 -16.66 75.00 -44,925 224,700
2015-02-04 2015-02-02 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -142 3,557 -3.84 88.15 -12,517 313,550
2015-02-03 2015-01-30 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -126 3,699 -3.29 87.51 -11,026 323,699
2015-02-02 2015-01-29 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 4,500 4,500
2015-02-02 2015-01-29 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 750 3,825 24.39
2015-01-28 2015-01-26 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -130 3,075 -4.06 88.83 -11,548 273,152
2015-01-21 2015-01-16 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -408 3,205 -11.29 88.67 -36,177 284,187
2015-01-21 2015-01-16 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 1,080 3,613 42.64
2014-11-24 2014-11-21 4 ETR ENTERGY CORP /DE/
Common Stock
S - Sale -1,200 2,508 -32.36 82.39 -98,868 206,634
2014-02-04 2014-01-31 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -159 3,599 -4.23 63.03 -10,022 226,845
2014-02-03 2014-01-30 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 5,200 5,200
2014-02-03 2014-01-30 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 1,150 3,758 44.10
2014-01-29 2014-01-27 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -242 2,608 -8.49 61.29 -14,832 159,844
2013-02-04 2013-01-31 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 5,000 5,000
2013-02-04 2013-01-31 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 1,200 2,736 78.12
2013-01-31 2013-01-29 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -228 1,536 -12.93 64.45 -14,695 98,995
2012-01-31 2012-01-27 4 ETR ENTERGY CORP /DE/
Common Stock
F - Taxes -81 1,686 -4.58 70.62 -5,720 119,065
2012-01-30 2012-01-26 4 ETR ENTERGY CORP /DE/
Employee Stock Option (Right to Buy)
A - Award 4,600 4,600
2012-01-30 2012-01-26 4 ETR ENTERGY CORP /DE/
Common Stock
A - Award 1,050 1,767 146.44
2010-06-21 3 ETR ENTERGY CORP /DE/
Common Stock
35
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)